Neurosciences -> Basic Science 355

355 - Enhancement of astatine (211At) uptake via the sodium iodide symporter by the addition of ascorbic acid in targeted alpha therapy of thyroid cancer (ID 1003)

Session Name
42 - Oncology, Basic and Translational (Basic Science) III
Speakers
Authors
Presentation Topic
Neurosciences -> Basic Science
Presentation Number
355

Previous Eposter
351 - Combination of 177Lu-lilotomab satetraxetan with rituximab synergistically improves in-vivo therapeutic efficacy in a rituximab-resistant non-Hodgkin lymphoma (NHL) model (ID 1000)

Next Eposters
362 - A Preliminary Investigation with 18F-NaF Dynamic PET/CT Brain Imaging for Primary Intracranial Tumors (ID 598)
363 - Differential diagnosis of radiotherapy injury and recurrent glioma by diffusion kurtosis imaging and 11C-Methionine metabolic imaging with PET/MR (ID 600)
369 - A study on the use of FDG180 via PET-CT for assessing bowel inflammation. (ID 524)
407 - Machine learning based quantitative analysis: an alternative method for traditional kinetic modeling based quantitative analysis of dynamic PET data (ID 510)
419 - [18F]Fluorodeoxyglucose (FDG) Imaging of Pre-Manifest Huntington’s Disease:Analysis by CAP Score (ID 1098)
420 - Altered brain metabolism and connectivity in temporal lobe epilepsy:an 18F-FDG PET study (ID 1099)
432 - Favorable outcome of patients treated by radioembolization of liver metastasis from uveal melanoma (ID 643)
447 - Evaluation of hybrid 18F-FDG PET/MR imaging of vulnerable plaque features in patients with carotid plaques (ID 1054)
467 - Co-treatment with Radium-223 and Enzalutamide: Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) from a Prospective Multicenter Observational Study (ID 1267)
470 - Tumor hypoxia evaluated by [F-18]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer (ID 920)